​

Mangoceuticals Stock (NASDAQ:MGRX)

RevenueFinancialsChart
Mangoceuticals by TradingView

Previous Close

$2.10

52W Range

$1.49 - $16.80

50D Avg

$3.53

200D Avg

$3.53

Market Cap

$16.06M

Avg Vol (3M)

$174.37K

Beta

2.42

Div Yield

-

MGRX Company Profile

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

3

IPO Date

Mar 21, 2023

Website

MGRX Performance

MGRX Financial Summary

Dec 24Dec 23Dec 22
Revenue$473.26K$731.49K$8.94K
Operating Income$-7.97M$-9.22M$-1.99M
Net Income$-8.71M$-9.21M$-2.00M
EBITDA$-7.97M$-9.19M$-1.99M
Basic EPS$-4.40$-6.45$-0.12
Diluted EPS$-4.40$-6.45$-0.12

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
HCTIHealthcare Triangle, Inc.
BFRGBullfrog AI Holdings, Inc. Common Stock
EUDAEUDA Health Holdings Limited